2007 (9) TMI 85 - AT - Central Excise

Tribunal reclassifies product 'QUI-9' under Chapter sub-heading 3003.20, highlights labeling importance

The Tribunal allowed the appeal filed by the Revenue, setting aside the impugned order and upholding the order of the adjudicating authority. The ... Classification of medicaments under Chapter 30 - definition of patent or proprietary medicaments - distinction between patent or proprietary medicaments and other medicaments - relevance of trade name/label prominence in tariff classification - application of precedent and consistency with earlier Tribunal decisionClassification of medicaments under Chapter 30 - definition of patent or proprietary medicaments - relevance of trade name/label prominence in tariff classification - application of precedent and consistency with earlier Tribunal decision - Classification of the product 'QUI-9' (Quinine Sulphate) as falling under Chapter sub-heading 3003.20 rather than sub-heading 3003.10. - HELD THAT: - The Tribunal examined the labels filed with the classification list and found that the product name 'QUI-9' is prominently and significantly displayed on the labels, indicating the absence of distinguishing words or monograms that would render the product a patent or proprietary medicament as contemplated in the Note to Chapter 30. The Tribunal held that where the prominent name on the product or its container is the generic name or where labelling does not satisfy the requirements for proprietary medicaments, the product must be classified under the residual heading for other medicaments. Reliance placed by the respondent on earlier decisions was rejected as misplaced on the facts, and the Tribunal followed its earlier decision in the appellant's own case (Order No. C-II/1330-31/WZB dated 17-5-2001) which dealt with identical issues and held similar products to merit classification under Chapter Heading No. 3003.20. Applying that precedent and the labelling-based test, the Tribunal found the Commissioner (Appeals) erred in upholding classification under sub-heading 3003.10 and therefore restored the adjudicating authority's classification under sub-heading 3003.20. [Paras 3, 4]Appeal allowed; impugned order set aside; order of the adjudicating authority upholding classification under Chapter sub-heading 3003.20 is restored.Final Conclusion: The Tribunal allowed the Revenue's appeal, holding that 'QUI-9' (Quinine Sulphate) is not a patent or proprietary medicament and must be classified under Chapter sub-heading 3003.20; the Commissioner (Appeals) order classifying it under sub-heading 3003.10 was set aside and the adjudicating authority's order restored. Issues involved:Classification of the product 'QUI-9' under sub-heading No. 3003.10 or Chapter sub-heading 3003.20.Analysis:The appeal was directed against Order-in-Appeal No. ZBN/464/MV/2001 dated 30-7-2001. Despite notice, none appeared on behalf of the respondent, but a written submission was considered. The issue revolved around the classification of the product 'QUI-9,' Quinine Sulphate Comprises BP. The respondents claimed classification under sub-heading No. 3003.10, while the revenue argued for classification under Chapter sub-heading 3003.20. The adjudicating authority classified it under Chapter Heading No. 3003.20, but the Commissioner (Appeals) upheld the classification under Chapter sub-heading No. 3003.10. The Tribunal noted that the product name 'QUI-9' was prominently displayed on the labels, indicating that it did not fall under Chapter 3003.10. The Tribunal referred to its earlier decision in the appellant's case regarding similar products, where it was held that the products should be classified under Chapter Heading No. 3003.20. The Tribunal found the reliance on certain decisions misplaced and, based on its previous ruling, allowed the appeal filed by the Revenue, setting aside the impugned order and upholding the order of the adjudicating authority.This judgment highlights the importance of the labeling and naming of products in determining their classification under specific tariff headings. The Tribunal emphasized that the prominent display of the product name 'QUI-9' on the labels influenced the classification decision. Additionally, the Tribunal referred to its previous rulings in similar cases involving the appellant, reinforcing the classification under Chapter Heading No. 3003.20. The judgment serves as a reminder of the significance of adherence to classification rules based on product characteristics and labeling information, as demonstrated through the analysis of the specific case of 'QUI-9' classification.